Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity ...
As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...
What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results